Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Completes Acquisition of BioSystem Development

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has completed the acquisition of BioSystem Development for an undisclosed sum.

The firm announced earlier this month that it would acquire the privately held maker of the AssayMAP microchromatography platform.

BioSystem Development, based in Madison, Wis., currently supplies Agilent's Automation Solutions business with AssayMap cartridges that are used with Agilent's Bravo liquid handling platform for protein purification and characterization workflows.

The agreement was announced at the same time Agilent said it had acquired next-generation sequencing sample preparation firm Halo Genomics, formerly known as Olink Genomics.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.